Jang, Raymond W <br/><br/>
Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 trial.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Sep 2009 
 - 4268-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2008.20.5815  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Canada<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cisplatin--administration & dosage<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Outcome Assessment, Health Care--methods<br/>Prospective Studies<br/>Quality of Life<br/>Randomized Controlled Trials as Topic<br/>Surveys and Questionnaires<br/>Survival Analysis<br/>Vinblastine--administration & dosage<br/>Vinorelbine